Trembleau S, Germann T, Gately M K, Adorini L
Roche Milano Ricerche, Italy.
Immunol Today. 1995 Aug;16(8):383-6. doi: 10.1016/0167-5699(95)80006-9.
The concept that T cells are subdivided into T helper 1 (Th1) and Th2 subsets was recently extended to suggest that Th1 cells contribute to the pathogenesis of several organ-specific autoimmune diseases, whereas Th2 cells inhibit disease development. Here, Sylvie Trembleau and colleagues examine the role of interleukin 12 (IL-12), a key cytokine guiding the development of Th1 cells, in the induction of autoimmune diseases, and discuss potential immunointervention strategies based on administration of IL-12 antagonists.
T细胞可细分为辅助性T细胞1(Th1)和辅助性T细胞2(Th2)亚群的概念最近得到扩展,表明Th1细胞参与了几种器官特异性自身免疫性疾病的发病机制,而Th2细胞则抑制疾病发展。在此,西尔维·特朗布莱及其同事研究了白细胞介素12(IL-12)——一种引导Th1细胞发育的关键细胞因子——在自身免疫性疾病诱导中的作用,并讨论了基于给予IL-12拮抗剂的潜在免疫干预策略。